Navigation
Home
Advocating for Access
Background
Letters for Access
Press Releases For Access
Simplified Community Materials
Simplified Community Materials
Understanding your HCV infection
Community Led Reports
Country Information
Indonesia
India
Vietnam
Generic DAAs Pricing
Resources
Guidelines
Key Research Publication
Other Important Documents and Reports
News
Gallery
Photos
Video
Stories
Response from CEO, CHAI about the Quick Start program in November 2016
Response from CEO, CHAI about the Quick Start program in November 2016
Please click here
December 21, 2016
/
News
Share
the Post
Related
Posts
Pricing of Indian generic sofosbuvir, 30th Jan,2016
BMS’ patent bid for Hep C treatment Daclatasvir Challenged
Read More
Story from Ayu Oktariani, Bandung, Indonesia
Four Indian generic companies take sub license from MPP on daclatasvir
Updated WHO screening, care and treatment of persons with hepatitis C infection_ April 2016.
Flawed patents on hepatitis C drugs latest to be challenged in global push for access
Hepatitis C Treatment Snapshots: Daclatasvir
Updated Patent Situation on Key Products for Hepatitis C Treatment in Asia – August 2015
